FDA Inspection
GlaxoSmithKline dba Human Genome Sciences IncGlaxoSmithKline dba Human Genome Sciences Inc – FDA Inspection, Mar 15, 2019
Record Details
This FDA Inspection record concerns GlaxoSmithKline dba Human Genome Sciences Inc, with an inspection on March 15, 2019, issued by the Baltimore District Office, covering human drugs.
- Inspection Date
- March 15, 2019
- Product Type
- Human Drugs
- Person
View Company Profile
ID · 5cd2b59d-c1b2-43c4-ba1b-83b846947807
Inspection Facts
- Inspection number
- 1108003
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of GlaxoSmithKline dba Human Genome Sciences Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2025 | Not classified | Baltimore District Office | |
| December 11, 2023 | Not classified | Baltimore District Office | |
| August 30, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for GlaxoSmithKline dba Human Genome Sciences Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.